Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.
Opioid-Induced Constipation (OIC)
DRUG: NKTR-118|DRUG: Usual care
Incidence of Patients Experiencing at Least One Adverse Event (AE), The incidence of patients experiencing at least one AE during the randomized treatment and follow-up periods was calculated., Baseline (Week 0) to end of the follow-up period|Incidence of Patients Experiencing AEs That Resulted in Discontinuation of Investigational Product (IP), The incidence of patients experiencing AEs that resulted in discontinuation of IP during the randomized treatment or follow-up periods was calculated., Baseline (Week 0) to end of the follow-up period|Incidence of Patients Experiencing Severe Adverse Events (SAEs), The incidence of patients experiencing SAEs during the randomized treatment and follow-up periods was calculated., Baseline (Week 0) to end of the follow-up period
The purpose of this study is to evaluate the long-term safety and tolerability of NKTR-118 treatment of opioid-induced constipation (OIC) in patients with non-cancer-related pain.